BIOATLA, INC. Increase (Decrease) in Prepaid Expense and Other Assets
BIOATLA, INC. (BCAB) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$181.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-13
- BIOATLA, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$418.00K.
- BIOATLA, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $237.00K, a 92.07% decline year-over-year.
- BIOATLA, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$455.00K.
- BIOATLA, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$1.06M.
- BIOATLA, INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$1.13M.
- BIOATLA, INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$2.90M, a 26490.91% decline from fiscal 2023.
- BIOATLA, INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $11.00K, a 99.58% decline from fiscal 2022.
- BIOATLA, INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $2.61M, a 1001.69% increase from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$418.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$181.00K 10-Q · filed 2026-08-13 | -$636.00K derived: sum of 3 quarters · filed 2026-08-13 | -$1.69M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2026-03-31 | $237.00K 10-Q · filed 2026-05-15 | -$218.00K derived: sum of 2 quarters · filed 2026-05-15 | -$1.27M derived: sum of 3 quarters · filed 2026-05-15 | -$3.88M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-12-31 | -$455.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$1.51M derived: sum of 2 quarters · filed 2026-03-31 | -$4.12M derived: sum of 3 quarters · filed 2026-08-13 | -$1.13M 10-K · filed 2026-03-31 | |
| 2025-09-30 | -$1.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$3.66M derived: sum of 2 quarters · filed 2026-08-13 | -$673.00K 10-Q · filed 2025-11-13 | -$2.54M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-06-30 | -$2.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $383.00K 10-Q · filed 2026-08-13 | -$1.48M derived: sum of 3 quarters · filed 2026-08-13 | -$2.26M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-03-31 | $2.99M 10-Q · filed 2026-05-15 | $1.12M derived: sum of 2 quarters · filed 2026-05-15 | $343.00K derived: sum of 3 quarters · filed 2026-05-15 | -$775.00K derived: sum of 4 quarters · filed 2026-05-15 | |
| 2024-12-31 | -$1.86M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$2.65M derived: sum of 2 quarters · filed 2026-03-31 | -$3.76M derived: sum of 3 quarters · filed 2026-03-31 | -$2.90M 10-K · filed 2026-03-31 | |
| 2024-09-30 | -$780.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$1.90M derived: sum of 2 quarters · filed 2025-11-13 | -$1.04M 10-Q · filed 2025-11-13 | -$2.33M derived: sum of 4 quarters · filed 2025-11-13 | |
| 2024-06-30 | -$1.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$258.00K 10-Q · filed 2025-08-07 | -$1.55M derived: sum of 3 quarters · filed 2025-08-07 | -$1.94M derived: sum of 4 quarters · filed 2025-08-07 | |
| 2024-03-31 | $860.00K 10-Q · filed 2025-05-06 | -$434.00K derived: sum of 2 quarters · filed 2025-05-06 | -$819.00K derived: sum of 3 quarters · filed 2025-05-06 | -$1.24M derived: sum of 4 quarters · filed 2025-05-06 | |
| 2023-12-31 | -$1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | -$1.68M derived: sum of 2 quarters · filed 2025-03-28 | -$2.10M derived: sum of 3 quarters · filed 2025-03-28 | $11.00K 10-K · filed 2025-03-28 | |
| 2023-09-30 | -$385.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$801.00K derived: sum of 2 quarters · filed 2024-11-07 | $1.30M 10-Q · filed 2024-11-07 | $1.04M derived: sum of 4 quarters · filed 2024-11-07 | |
| 2023-06-30 | -$416.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $1.69M 10-Q · filed 2024-08-08 | $1.43M derived: sum of 3 quarters · filed 2024-08-08 | $1.71M derived: sum of 4 quarters · filed 2024-08-08 | |
| 2023-03-31 | $2.11M 10-Q · filed 2024-05-14 | $1.84M derived: sum of 2 quarters · filed 2024-05-14 | $2.12M derived: sum of 3 quarters · filed 2024-05-14 | $2.44M derived: sum of 4 quarters · filed 2024-05-14 | |
| 2022-12-31 | -$265.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | $16.00K derived: sum of 2 quarters · filed 2024-03-26 | $333.00K derived: sum of 3 quarters · filed 2024-03-26 | $2.61M 10-K · filed 2024-03-26 | |
| 2022-09-30 | $281.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $598.00K derived: sum of 2 quarters · filed 2023-11-07 | $2.88M 10-Q · filed 2023-11-07 | $1.60M derived: sum of 4 quarters · filed 2023-11-07 | |
| 2022-06-30 | $317.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $2.60M 10-Q · filed 2023-08-01 | $1.32M derived: sum of 3 quarters · filed 2023-08-01 | $186.00K derived: sum of 4 quarters · filed 2023-08-01 | |
| 2022-03-31 | $2.28M 10-Q · filed 2023-05-11 | $999.00K derived: sum of 2 quarters · filed 2023-05-11 | -$131.00K derived: sum of 3 quarters · filed 2023-05-11 | $1.21M derived: sum of 4 quarters · filed 2023-05-11 | |
| 2021-12-31 | -$1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | -$2.41M derived: sum of 2 quarters · filed 2023-03-23 | -$1.07M derived: sum of 3 quarters · filed 2023-03-23 | $237.00K 10-K · filed 2023-03-23 | |
| 2021-09-30 | -$1.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $209.00K derived: sum of 2 quarters · filed 2022-11-04 | $1.52M 10-Q · filed 2022-11-04 | $2.81M derived: sum of 4 quarters · filed 2022-11-04 | |
| 2021-06-30 | $1.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $2.65M 10-Q · filed 2022-08-09 | $3.94M derived: sum of 3 quarters · filed 2022-08-09 | $4.31M derived: sum of 4 quarters · filed 2022-08-09 | |
| 2021-03-31 | $1.31M 10-Q · filed 2022-05-05 | -$1.31M 10-Q · filed 2021-05-12 | $2.60M derived: sum of 2 quarters · filed 2022-05-05 | $2.97M derived: sum of 3 quarters · filed 2022-05-05 | $2.17M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $1.66M derived: sum of 2 quarters · filed 2022-02-28 | $859.00K derived: sum of 3 quarters · filed 2022-02-28 | $1.27M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $364.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$439.00K derived: sum of 2 quarters · filed 2021-11-15 | -$25.00K 10-Q · filed 2021-11-15 | ||
| 2020-06-30 | -$803.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | -$389.00K 10-Q · filed 2021-08-13 | |||
| 2020-03-31 | $414.00K 10-Q · filed 2021-05-12 | ||||
| 2019-12-31 | -$939.00K 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |